News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 4, 2021
2021
Press Release Regulatory

Nomination Committee for Elicera Therapeutics appointed

Regulatory Press Release
Read more
Oct 22, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics appoints professor Gunilla Enblad, Key Opinion Leader within the fields of CAR T-cells and B-cell lymphoma, as scientific advisor

Non-regulatory Press Release
Read more
Oct 20, 2021
2021
Press Release Regulatory

Elicera Therapeutics presents preclinical proof-of-concept data for its iTANK-platform at the European Society of Cell & Gene Therapy Congress

Regulatory Press Release
Read more
Oct 20, 2021
2021
News

Nordic Life Science News

News
Read more
Oct 5, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics announces participation in several industry and investor meetings in October and November

Non-regulatory Press Release
Read more
Sep 13, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics will present the iTANK platform orally at ESGCT Collaborative Virtual Congress and PEGS Europe

Non-regulatory Press Release
Read more
Aug 20, 2021
2021
Press Release Non-regulatory

Interim Report Elicera Therapeutics AB January – June 2021

Non-regulatory Press Release
Read more
Jul 5, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics’ warrants (TO1) are listed on First North Growth Market

Non-regulatory Press Release
Read more
Jul 5, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics' board and management buy shares

Non-regulatory Press Release
Read more
Jun 24, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics receives ATMP-classification from EMA for oncolytic virus

Non-regulatory Press Release
Read more
Jun 10, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics has been approved for listing on Nasdaq First North Growth Market

Non-regulatory Press Release
Read more
Jun 9, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics' new issue heavily oversubscribed

Non-regulatory Press Release
Read more
Jun 4, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics’ last day to subscribe ahead of the listing at Nasdaq First North Growth Market

Non-regulatory Press Release
Read more
Jun 3, 2021
2021
News

CEO-interview by Nyhetsbyrån Direkt

News
Read more
May 31, 2021
2021
News

Article in "Forskning och framsteg"

News
Read more
May 24, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics’ first day to subscribe ahead of the listing at Nasdaq First North Growth Market

Non-regulatory Press Release
Read more
May 18, 2021
2021
News

Eliceras CEO, Jamal El-Mosleh, recognized on In Vivo’s list of 30 Rising Leaders across the biopharma, medtech and health technology sectors.

News
Read more
May 17, 2021
2021
News

Company presentation at "Aktiedagen Göteborg".

News
Read more
Apr 27, 2021
2021
Press Release Non-regulatory

Elicera Therapeutics files a patent application for the development of the next generation oncolytic viruses

Non-regulatory Press Release
Read more
Apr 15, 2021
2021
Press Release Non-regulatory

Biostock writes about Elicera and CAR T-cells

Non-regulatory Press Release
Read more

Sign up for Press Releases

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
By continuing to browse this website you agree to cookies being stored on your device in order to improve the experience and analyze how it is being used. Read more in our Integrity policy.